Your session is about to expire
← Back to Search
Monoclonal Antibodies + Cyclosporine + Paclitaxel for Breast Cancer
Study Summary
This trial will use radiolabeled monoclonal antibodies to target and kill cancer cells while sparing normal cells. Cyclosporine and paclitaxel will be used to help the monoclonal antibodies work better. The goal is to learn if this combination treatment is effective and safe.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I had high-dose chemotherapy with my own stem cells over a year ago, without using carmustine.It has been over 4 weeks since my last chemotherapy session.I am not on blood thinners, except possibly low-dose warfarin for a central line.My cancer came back or didn't fully go away after my first chemotherapy.My breast cancer has spread and was confirmed by a lab test.I have undergone at least one chemotherapy treatment for my advanced disease.I haven't had radiation on more than a quarter of my bones.My tumor cells are positive for a specific protein marker.My cancer has spread to other parts of my body.It has been over 4 weeks since my last external beam radiotherapy.I am mostly able to care for myself and carry out daily activities.I haven't had any cancer in the last 5 years, except for skin cancer or treated cervical cancer.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this medical approach well-tolerated in patients?
"Power's assessment of this treatment places its safety at a 1, as it is yet to pass Phase 1 trials and thus has limited evidence for efficacy or security."
Is enrollment currently available for this trial?
"The clinicaltrials.gov database confirms that, though posted on March 1st 2001 and last updated September 19th 2013, this medical trial is presently not enrolling candidates. However, there are currently 2600 other studies seeking participants."
Share this study with friends
Copy Link
Messenger